ICER Suggests Price Of $2,500-$8,300 For Biogen’s Aducanumab

Cost Watchdog Sees Insufficient Data To Show Health Benefit

 
• By Mandy Jackson
  
The old man leaves the road among the trees. Alzheimer's disease and withdrawal from life.
ICER said aducanumab's benefit in Alzheimer's disease is unclear • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip